Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Nicholas L. M. Cruden

Centre for Cardiovascular Science

University of Edinburgh

Room F2339

Royal Infirmary of Edinburgh

[email]@ed.ac.uk

Name/email consistency: high

[Claim this account]

Affiliations

Centre for Cardiovascular Science, University of Edinburgh, Room F2339, Royal Infirmary of Edinburgh, UK. 2004 - 2011
Victoria Heart Institute Foundation, Victoria, British Columbia, Canada. 2011
University of Edinburgh, Centre for Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, UK. 2008
Department of Cardiology, Royal Infirmary of Edinburgh, Little France Crescent, Little France, UK. 2008

References

Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Cruden, N.L., Lang, N.N., Macgillivray, T.J., Uren, N.G., Fox, K.A., Newby, D.E. Heart. Vessels (2011) [Pubmed]
Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting. Cruden, N.L., Morch, K., Wong, D.R., Klinke, W.P., Ofiesh, J., Hilton, J.D. Am. Heart J. (2011) [Pubmed]
Therapeutic potential of icatibant (HOE-140, JE-049). Cruden, N.L., Newby, D.E. Expert. Opin. Pharmacother (2008) [Pubmed]
Isolated left ventricular non-compaction as an unusual cause of heart failure: a case report. Cruden, N.L., Denvir, M.A. J. Medical Case Reports (2008) [Pubmed]
Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction. Cruden, N.L., Graham, C., Harding, S.A., Ludlam, C.A., Fox, K.A., Newby, D.E. Thromb. Res. (2006) [Pubmed]
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure. Cruden, N.L., Tse, G.H., Fox, K.A., Ludlam, C.A., Megson, I., Newby, D.E. Arterioscler. Thromb. Vasc. Biol. (2005) [Pubmed]
Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden, N.L., Witherow, F.N., Webb, D.J., Fox, K.A., Newby, D.E. Arterioscler. Thromb. Vasc. Biol. (2004) [Pubmed]
Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition. Cruden, N.L., Fox, K.A., Ludlam, C.A., Johnston, N.R., Newby, D.E. Hypertension (2004) [Pubmed]
Angiotensin antagonism in patients with heart failure: ACE inhibitors, angiotensin receptor antagonists or both?. Cruden, N.L., Newby, D.E. Am. J. Cardiovasc. Drugs (2004) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.